Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan.
about
Antibiotic treatment for Helicobacter pylori: Is the end coming?Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature reviewSecond and third line treatment options for Helicobacter pylori eradicationThe clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradicationGeranylgeranylacetone selectively binds to the HSP70 of Helicobacter pylori and alters its coccoid morphology.Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South KoreaLow efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy.Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan.Current recommendations for Helicobacter pylori therapies in a world of evolving resistance.Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis.Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease.Treatment of Helicobacter pylori infection 2013.Attempts to enhance the eradication rate of Helicobacter pylori infectionTreatment of Helicobacter pylori infection 2014.Quinolone-containing therapies in the eradication of Helicobacter pyloriChallenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains.Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.High Helicobacter pylori cure rate with sitafloxacin-based triple therapy.A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.Evidence-based clinical practice guidelines for peptic ulcer disease 2015.Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients.Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithm - author's reply.Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens.Current Status of the Third-Line Helicobacter pylori Eradication.Fourth-generation quinolones in the treatment of infection: A meta-analysisEfficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
P2860
Q26777623-A027412F-4B57-4F82-8368-820D704ABDCBQ26785651-3D2C219B-0D12-4DFC-9305-ED6E2DE92253Q26829666-FA77161B-C97F-4075-93A4-A89369778F80Q28542458-82C54097-D1B8-4459-ADD2-5304AB31260CQ30402933-DA99B107-72F5-4B85-A549-956B9FB00393Q33735315-DA2DE74D-049C-4F44-9A17-9C2B9904C790Q35692337-3AE96121-0C10-4DC6-895D-C8CB86D1F438Q36979151-B7B4D2E9-4408-470E-B39A-1C1AB34F73EDQ37378899-753C4465-31AB-4E58-9FF5-53ED92B8A96CQ37491386-45030DBF-6F8B-4484-A8A1-630F4A415AD7Q37591509-11AD54D0-8AEA-4CE3-9134-54C8196E5238Q37694256-F59A0104-583C-438E-8986-87FD31DC78AFQ37696038-F56379D6-2024-4D59-8EF1-AC48ED8C21ECQ38134877-F5B41240-C86B-4F26-A0A6-BEC243B87B02Q38212213-8D76C079-EE8F-4AC1-B3EA-1E282DE42C65Q38244257-DC4971FD-44D5-461F-A75E-904B0A497E06Q38253054-93F2C8F1-2426-4F0D-B242-563647B8B63DQ38496942-D60A51DB-4A61-4688-A56B-8CA70487D7B3Q38650879-A0FBDA98-D7B8-49E3-8DED-DBFAF662FEDDQ39014376-E49BC7CC-29E6-4B3F-B87F-34B56A77C2C7Q39496571-81EA2472-2871-47C6-AA97-D872F8A17E5FQ39496596-95BC1482-50BE-4C31-9FDD-D671CE526BEEQ40074608-A2F60880-383A-4F25-A3F7-76019F75F811Q40378087-994EBBCD-5141-4377-92E7-A4C8B8C4BCE5Q40790399-7F853720-1844-4682-9316-0E1D51C0D1FFQ40892650-32F7878A-03BC-4104-B926-10D3C2D04D4CQ42284208-461ACD6A-30D7-454D-BFA1-E1A2B85CCDECQ47995761-AC8AA4BD-3851-41DE-998E-CEBF13CAE531Q48600558-5084F16C-D537-4968-95D4-1C94946E5E35Q50860239-5A03624B-8488-42F8-A72E-4446B2844EF1Q54945494-9B78382E-49E6-4756-9A75-7619E37EC260Q55056772-4FC402C5-4985-4C2B-AC1A-E765843E8209Q58798109-14FB6F2E-F823-48A0-B483-017E3062B5C0Q59135299-5EDF61BC-79F1-46DE-AAAF-87DA24A75AE5
P2860
Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Multi-center randomized contro ...... r pylori eradication in Japan.
@en
Multi-center randomized contro ...... r pylori eradication in Japan.
@nl
type
label
Multi-center randomized contro ...... r pylori eradication in Japan.
@en
Multi-center randomized contro ...... r pylori eradication in Japan.
@nl
prefLabel
Multi-center randomized contro ...... r pylori eradication in Japan.
@en
Multi-center randomized contro ...... r pylori eradication in Japan.
@nl
P2093
P2860
P1476
Multi-center randomized contro ...... r pylori eradication in Japan.
@en
P2093
Hideyuki Nomura
Japan GAST Study Group
Junichi Iwamoto
Katsuhiro Mabe
Kazunari Murakami
Kenji Amagai
Kiichi Satoh
Makoto Sasaki
Masaaki Kodama
P2860
P304
P356
10.1007/S00535-012-0731-8
P577
2013-01-11T00:00:00Z